a year ago
IOVA
AnalystsAsthika GoonewardeneAsthika Goonewardene's Stock Forecasts
AnalystsAsthika Goonewardene
Sectors:
Industries:
Analyst Ranking
Bottom 4%
#4762 out of 4923 analysts
Average Return
-8.64%
Win Rate
39%35 out of 90
Risk vs Reward
Poor
Good
Asthika Goonewardene's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Immunogen IncIMGN | +180.83% | $5.32 | $14.94 | 2022-11-20 - 2023-11-20 | Strong Buy |
Forty Seven IncFTSV | +163.68% | $35.74 | $94.24 | 2020-01-12 - 2020-03-03 | Strong Buy |
Sutro Biopharma IncSTRO | +111.24% | $12.01 | $25.37 | 2020-01-12 - 2021-01-13 | Strong Buy |
Immunogen IncIMGN | +106.14% | $15.15 | $31.23 | 2023-06-05 - 2024-02-09 | Strong Buy |
Iovance Biotherapeutics IncIOVA | +96.20% | $5.27 | $10.34 | 2023-09-14 - 2024-09-13 | Strong Buy |
Asthika Goonewardene Analyst Color
Get additional color on Asthika Goonewardene's coverage of popular stocks
a year ago
ACLX
Asthika Goonewardene's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Exelixis IncEXEL | 8 | Strong Buy | $55.00 | +24.79% | Reiterates | 9 days ago |
Igm Biosciences IncIGMS | 9 | Hold | $1.00 | -10.71% | Maintains | 20 days ago |
Biontech SeBNTX | 2 | Strong Buy | $155.00 | +45.58% | Reiterates | a month ago |
Mersana Therapeutics IncMRSN | 3 | Strong Buy | $10.00 | +3,278.38% | Maintains | 2 months ago |
Legend Biotech CorpLEGN | 2 | Strong Buy | $71.00 | +100.06% | Maintains | 2 months ago |
Allogene Therapeutics IncALLO | 6 | Strong Buy | $10.00 | +784.96% | Maintains | 2 months ago |
Autolus Therapeutics PLCAUTL | 4 | Strong Buy | $10.00 | +338.60% | Maintains | 3 months ago |
Genmab AGMAB | 12 | Strong Buy | $45.00 | +117.81% | Maintains | 4 months ago |
Iovance Biotherapeutics IncIOVA | 6 | Strong Buy | $15.00 | +772.09% | Maintains | 4 months ago |
Cargo Therapeutics IncCRGX | 3 | Hold | $7.00 | +69.90% | Downgrades | 5 months ago |
Summit Therapeutics IncSMMT | 1 | Strong Buy | $35.00 | +64.47% | Initiates Coverage On | 6 months ago |
Arcellx IncACLX | 5 | Strong Buy | $136.00 | +106.53% | Maintains | 8 months ago |
Gilead Sciences IncGILD | 1 | Hold | $97.00 | -12.51% | Maintains | 8 months ago |
Sutro Biopharma IncSTRO | 6 | Strong Buy | $15.00 | +2,000.84% | Maintains | a year ago |
Arcus Biosciences IncRCUS | 1 | Strong Buy | $44.00 | N/A | Maintains | a year ago |
Merus NvMRUS | 2 | Strong Buy | $88.00 | N/A | Maintains | a year ago |
Compugen LtdCGEN | 5 | Strong Buy | $4.00 | N/A | Maintains | a year ago |
Caribou Biosciences IncCRBU | 3 | Strong Buy | $19.00 | N/A | Maintains | a year ago |
Seagen IncSGEN | 3 | Hold | $229.00 | N/A | Reiterates | 2 years ago |
Hookipa Pharma IncHOOK | 4 | Strong Buy | $40.00 | N/A | Reiterates | 2 years ago |
Adicet Bio IncACET | 2 | Strong Buy | $27.00 | N/A | Reiterates | 2 years ago |
Immunogen IncIMGN | 2 | Strong Buy | $18.00 | N/A | Maintains | 2 years ago |
Instil Bio IncTIL | 1 | Hold | $120.00 | N/A | Reinstates | 2 years ago |
Tcr2 Therapeutics IncTCRR | 3 | Hold | $3.00 | N/A | Downgrades | 2 years ago |
Harpoon Therapeutics IncHARP | 3 | Hold | $20.00 | N/A | Downgrades | 3 years ago |
Celularity IncCELU | 2 | Hold | $60.00 | N/A | Maintains | 3 years ago |
Nextcure IncNXTC | 4 | Strong Buy | $15.00 | N/A | Maintains | 3 years ago |
Forty Seven IncFTSV | 2 | Hold | $95.50 | N/A | Downgrades | 5 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.